(Q37985523)

26 August 2017

title

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment (English)

1 reference

26 August 2017

0 references

0 references

Maya Koronyo-Hamaoui

4

1 reference

ORCID Public Data File 2021

author name string

Yosef Koronyo

series ordinal

1

1 reference

26 August 2017

Brenda C Salumbides

series ordinal

2

1 reference

26 August 2017

Keith L Black

series ordinal

3

1 reference

26 August 2017

publication date

10 February 2012

1 reference

Neurodegenerative Diseases

26 August 2017

published in

1 reference

26 August 2017

volume

10

1 reference

26 August 2017

issue

1-4

1 reference

26 August 2017

page(s)

285-293

1 reference

Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment

26 August 2017

cites work

1 reference

Early behavioral symptoms and course of Alzheimer's disease

21 January 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias

21 January 2018

1 reference

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

Regulation of tau phosphorylation in Alzheimer's disease

21 January 2018

1 reference

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence.

21 January 2018

1 reference

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

21 January 2018

1 reference

Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker

21 January 2018

1 reference

Early diagnosis and treatment of Alzheimer's disease

21 January 2018

1 reference

Effective pharmacologic management of Alzheimer's disease

21 January 2018

1 reference

Amyloid imaging in early detection of Alzheimer's disease

21 January 2018

1 reference

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

21 January 2018

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system.

21 January 2018

1 reference

Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease

21 January 2018

1 reference

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease

21 January 2018

1 reference

In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe

21 January 2018

1 reference

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

21 January 2018

1 reference

CSF biomarker levels in early and late onset Alzheimer's disease

21 January 2018

1 reference

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.

21 January 2018

1 reference

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

21 January 2018

1 reference

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.

21 January 2018

1 reference

Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease.

21 January 2018

1 reference

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

21 January 2018

1 reference

Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.

21 January 2018

1 reference

CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia.

21 January 2018

1 reference

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid

21 January 2018

1 reference

Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.

21 January 2018

1 reference

MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice

21 January 2018

1 reference

SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.

21 January 2018

1 reference

Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits

21 January 2018

1 reference

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease

21 January 2018

1 reference

Ocular biomarkers for early detection of Alzheimer's disease

21 January 2018

1 reference

21 January 2018

Focus on: amyloid beta.

1 reference

The eye in cerebral malaria: what can it teach us?

21 January 2018

1 reference

Vertebrate retina and hypothalamus development

21 January 2018

1 reference

Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.

21 January 2018

1 reference

Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina

21 January 2018

1 reference

Optic-nerve degeneration in Alzheimer's disease.

21 January 2018

1 reference

Morphological and functional retinal impairment in Alzheimer's disease patients

21 January 2018

1 reference

Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila.

21 January 2018

1 reference

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

21 January 2018

1 reference

Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

21 January 2018

1 reference

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease

21 January 2018

1 reference

Complement-associated deposits in the human retina

21 January 2018

1 reference

Ophthalmologic manifestations of Alzheimer's disease

21 January 2018

1 reference

Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?

21 January 2018

1 reference

Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type.

21 January 2018

1 reference

Alzheimer's disease: visual system review.

21 January 2018

1 reference

Retinal abnormalities in early Alzheimer's disease

21 January 2018

1 reference

Retinal ganglion cells in Alzheimer's disease and aging.

21 January 2018

1 reference

Alzheimer's disease and retinal neurodegeneration.

21 January 2018

1 reference

Optical coherence tomography of the retina: applications in neurology

21 January 2018

1 reference

Local neuroinflammation and the progression of Alzheimer's disease

21 January 2018

1 reference

Beta-amyloid plaques: stages in life history or independent origin?

21 January 2018

1 reference

Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice

21 January 2018

1 reference

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging

21 January 2018

1 reference

Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography

21 January 2018

1 reference

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Recent developments in optical coherence tomography for imaging the retina.

21 January 2018

1 reference

Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease

21 January 2018

1 reference

Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo

21 January 2018

1 reference

Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.

21 January 2018

1 reference

Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility.

21 January 2018

1 reference

Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease

21 January 2018

1 reference

Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.

21 January 2018

1 reference

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

21 January 2018

1 reference

A potential role of the curry spice curcumin in Alzheimer's disease

21 January 2018

1 reference

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

21 January 2018

1 reference

Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model.

21 January 2018

1 reference

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.

21 January 2018

1 reference

Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease.

21 January 2018

1 reference

Targeting amyloid-beta in glaucoma treatment.

21 January 2018

1 reference

Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model

21 January 2018

1 reference

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000335154

1 reference

26 August 2017

1 reference